Comment on: "Cell Therapy for Heart Disease: Trial Sequential Analyses of Two Cochrane Reviews"
Articolo
Data di Pubblicazione:
2017
Citazione:
Comment on: "Cell Therapy for Heart Disease: Trial Sequential Analyses of Two Cochrane Reviews" / G. Castellini, E.E. Nielsen, C. Gluud. - In: CLINICAL PHARMACOLOGY & THERAPEUTICS. - ISSN 0009-9236. - 102:1(2017 Jul), pp. 21-24. [10.1002/cpt.536]
Abstract:
Trial Sequential Analysis is a frequentist method to help researchers control the risks of random errors in meta-analyses (1). Fisher and colleagues used Trial Sequential Analysis on cell therapy for heart diseases (2). The present article discusses the usefulness of Trial Sequential Analysis and its dependence on the choice of the parameters for calculation of the required information size and the adjacent monitoring boundaries, and comments on the approach by Fisher et al. (2).
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Trial Sequential Analysis; cardiovascular diseases; stem cells
Elenco autori:
G. Castellini, E.E. Nielsen, C. Gluud
Link alla scheda completa: